When considering options in the biotech sector, experts often look more into the major companies providing massive amounts of resources to new candidates.
When considering options in the biotech sector, experts often look more into the major companies providing massive amounts of resources to new candidates. Gains for investors can be hard to find on the mid to small cap area of the industry. However, this year there was no shortage of companies achieving success and moving up the ranks.
